Neurelis
PrivateLast Round
Series D
Aug 26, 2022
Total Funding Raised
$391.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neurelis is a neuroscience company that develops and commercializes therapeutics for the treatment of epilepsy and other central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurelis Comps
Public and private peers based on sector, stage, and business model.
Neurelis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 26, 2022 | ||||
| Debt | Aug 11, 2021 | ||||
| Series D | Mar 10, 2021 | ||||
| Series D | Oct 21, 2020 | ||||
| Series C | Nov 8, 2018 | ||||
Series B | Jan 5, 2017 |
Neurelis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CMS Medical Venture Investment (HK) Limited | Series C |
| LYZZ Capital | Series C, Series B, Series A, Series D |
| Cormorant Asset Management | Series D |
| OrbiMed | Debt |
| HBM Healthcare Investments | Series D, Series C, Series B |
| Philos & Partners Ltd. | Series D |
| Cormorant Asset Management | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 38% MoM.
- Apr 23, 2026
Attending Epilepsy Awareness Day at Walt Disney World.
Neurelis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurelis's valuation, stock price, and market status.
